glp-1 drugs and lupus Risk of End-Stage Renal Disease Among Patients with Nephritis on Receptor Agonists: A Retrospective Cohort Study Glucagon-like peptide-1 receptor: mechanisms and

doi:10.1210/clinem/dgaa863 25

Statements Author contributions All authors listed have made a substantial, direct, and intellectual contribution to the work and approved it for publication

For patients with specific concerns about retatrutide and hair loss , dedicated guidance is also available

GLP-1 receptors are found throughout the body and within the brain and can have multi-system effects, including our reward-based eating

GLP-1, GIP & Inflammation: What These Medications Really Do and What They Dont Joshua Silva, MD Dec 5, 2025 7 min read Updated: Jan 27 Medically authored by Joshua Silva, MD | Evidence-Based Weight Loss at Potere Health MD Quick Answer GLP-1 and GLP-1/GIP medications (such as semaglutide and tirzepatide ) can lower metabolic inflammation by improving insulin resistance, reducing visceral fat, and lowering inflammatory biomarkers such as C-reactive protein (CRP) ., They can also improve cardiometabolic risk markers (e.g., blood pressure) and, for tirzepatide, can improve atherogenic lipoprotein measures including apoB and triglyceride-rich lipoproteins in clinical research settings., They do not treat autoimmune diseases or fibromyalgia directly

Satiety and Blood Sugar Regulation Berries have a low glycemic index, which means they digest slowly and help prevent sudden blood sugar spikes